ISSN: 1472-8222
Journal Home
Journal Guideline
Expert Opinion on Therapeutic Targets Q1 Unclaimed
Expert Opinion on Therapeutic Targets is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 106. It has a price of 4000 €. It has an SJR impact factor of 1,423 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,423.
Expert Opinion on Therapeutic Targets focuses its scope in these topics and keywords: target, therapeutic, potential, receptor, histone, immunotherapy, leukemiaanaplastic, lymphoma, illnessis, methylationnf?b, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -
4000 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
1,423
SJR Impact factor106
H Index103
Total Docs (Last Year)274
Total Docs (3 years)11531
Total Refs1287
Total Cites (3 years)245
Citable Docs (3 years)3.99
Cites/Doc (2 years)111.95
Ref/DocOther journals with similar parameters
Protein & Cell Q1
Molecular Therapy Q1
Nature Reviews Drug Discovery Q1
Medicinal Research Reviews Q1
Cell Chemical Biology Q1
Compare this journals
Aims and Scope
Best articles by citations
Modulation of apoptosis as a target for liver disease
View moreMolecular targets in immune-mediated diseases: focus on rheumatoid arthritis
View moreOncogene-targeted antisense oligonucleotides for the treatment of Ewing sarcoma
View morePyruvate dehydrogenase as a therapeutic target for obesity cardiomyopathy
View moreMolecular targets in the inhibition of angiogenesis
View moreTIPE2 as a potential therapeutic target in chronic viral hepatitis
View moreThe therapeutic potential of neuronal KCNQ channel modulators
View moreReceptor tyrosine kinase-like orphan receptor 1: a novel target for cancer immunotherapy
View moreThe MAP kinase-interacting kinases (MNKs) as targets in oncology
View moreFunctional genetic evaluation of DNA house-cleaning enzymes in the malaria parasite: dUTPase and Ap4AH are essential in Plasmodium berghei but ITPase and NDH are dispensable
View moreG-Protein-Coupled Receptors: New Approaches to Maximise the Impact of GPCRs in Drug Discovery
View moreSuperoxide dismutase: an emerging target for cancer therapeutics
View moreAn in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients
View moreHistone deacetylase inhibitors: insights into mechanisms of lethality
View moreThe plastid-derived organelle ofprotozoan human parasites asa target of established and emerging drugs
View moreRecent advances towards identification of new drug targets for Mycobacterium tuberculosis
View moreTargeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation
View moreMechanisms of MHC class I-restricted antigen presentation
View moreTargeting the cell signaling pathway Keap1-Nrf2 as a therapeutic strategy for adenocarcinomas of the lung
View moreTherapeutic targets for antimetastatic therapy
View moreTargeted therapies for prostate cancer
View moreDeath associated protein kinase as a potential therapeutic target
View moreNew developments in the urokinase-type plasminogen activator system
View moreNon-coding RNAs as direct and indirect modulators of epigenetic mechanism regulation of cardiac fibrosis
View more
Comments